Tarsus Pharmaceuticals Inc. (TARS) Social Stream



Tarsus Pharmaceuticals Inc. (TARS): $14.42

-0.07 (-0.48%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add TARS to Watchlist
Sign Up

Industry: Biotech


Ranked

of 392

in industry

Tarsus Pharmaceuticals Inc (TARS) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering TARS.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 5 $67 $45 $56.8 $17.75 220%
2021-11-23 6 $68 $45 $57.166 $17.75 222.06%
2022-03-15 7 $68 $40 $54.714 $17.75 208.25%
2022-03-17 7 $69 $40 $54.857 $17.75 209.05%

The Trend in the Analyst Price Target


TARS's average price target has moved up $13.26 over the prior 48 weeks.

TARS reports an average of 107.44% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-07-24 4 67 45 51.2 25.91 97.61%
2021-08-07 4 67 45 53.8 25.00 115.2%
2021-08-28 4 67 45 53.8 25.49 111.06%
2021-11-10 6 68 45 57.6 28.10 104.98%
2021-11-10 6 67 45 56.8 28.10 102.14%

TARS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 7 0 0 0 0 7

The Trend in the Broker Recommendations


Over the past 120 days, TARS's average broker recommendation rating improved by 0.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how Tarsus Pharmaceuticals Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 625.38% of that group.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, Tarsus Pharmaceuticals Inc's average analyst price target is higher than 638.17% of them.
  • In the context of stocks in the small market cap category, Tarsus Pharmaceuticals Inc's number of analysts covering the stock is higher than 543.32% of them.
  • Tarsus Pharmaceuticals Inc's variance in analysts' estimates is lower than -159.69% of Pharmaceutical Products stocks.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Tarsus Pharmaceuticals Inc are TALS, SURF, and STRO.

Is TARS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4919 seconds.